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Translational readthrough gives rise to C-terminally extended proteins,
thereby providing the cell with new protein isoforms. These may have differ-
ent properties from the parental proteins if the extensions contain functional
domains. While for most genes amino acid incorporation at the stop codon is
far lower than 0.1%, about 4% of malate dehydrogenase (MDH1) is physio-
logically extended by translational readthrough and the actual ratio of
MDH1x (extended protein) to ‘normal’ MDH1 is dependent on the cell
type. In human cells, arginine and tryptophan are co-encoded by the
MDH1x UGA stop codon. Readthrough is controlled by the 7-nucleotide
high-readthrough stop codon context without contribution of the sub-
sequent 50 nucleotides encoding the extension. All vertebrate MDH1x is
directed to peroxisomes via a hidden peroxisomal targeting signal (PTS) in
the readthrough extension, which is more highly conserved than the exten-
sion of lactate dehydrogenase B. The hidden PTS of non-mammalian
MDH1x evolved to be more efficient than the PTS of mammalian MDH1x.
These results provide insight into the genetic and functional co-evolution
of these dually localized dehydrogenases.1. Introduction
Decoding of stop codons as sense codons is known as translational readthrough
or stop codon suppression and was first described in viruses [1–3]. Later, pro-
karyotic, eukaryotic and additional viral genes were discovered that are
naturally readthrough [4–7]. Bioinformatic approaches and ribosome
profiling in Drosophila identified genes displaying translational readthrough
[8–10], and readthrough in mammals was also reported for several singular
genes [5,6,8,9,11–17].
How readthrough is controlled at the ribosome is not clear, but the first
trans-acting factors interacting with the termination complex are being uncov-
ered [18,19]. On the level of the RNA, readthrough efficiency is determined
by the stop codon itself and by elements more distantly located on the
mRNA [12,20–24]. Moreover, the nucleotides surrounding the stop codon,
referred to here as the stop codon context (SCC), have an impact on read-
through efficiency [2,25–29]. Recently, we developed a linear regression
model for a genome-wide in silico readthrough analysis focusing on transla-
tional readthrough that depends on the SCC [15]. This model computes a
readthrough propensity (RTP) score for the SCC of every human transcript.
Using the regression coefficients of this model, we derived a consensus for
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through rate by at least one order of magnitude, from less
than 0.1% to more than 1% [14–16].
It is noteworthy that SCC-dependent readthrough can
be obtained without pharmacological modification of the ribo-
somal stop fidelity. Drug-induced increase in readthrough, on
the other hand, is considered a therapeutic option in some gen-
etic diseases that are caused by a premature stop codon
mutation [30,31]. Most of the drugs that are currently being
tested are aminoglycosides or their derivatives. These bind to
the small subunit of the ribosome and reduce discrimination
of near-cognate tRNAs [32].
Peroxisomes are cellular organelles involved in fatty acid
b-oxidation and degradation of hydrogen peroxide [33]. In
mammalian cells, peroxisomes degrade complex fatty acids
such as branched chain fatty acids and very long-chain
fatty acids, and also synthesize bile acids [34]. Most luminal
proteins contain a peroxisomal targeting signal type 1
(PTS1) at the very C-terminus, for example the canonical tri-
peptide serine-lysine-leucine (SKL) [35]. However, even the
classical SKL tripeptide is not always a PTS1 as more than
the three terminal amino acids are involved in the targeting
process [36]. The substrates themselves may or may not be
oligomers during import [37,38].
Functional translational readthrough gives rise to new
protein isoforms with biological functions distinct from that
of the original protein. Ribosomal readthrough in fungi, for
example, leads to peroxisomal targeting of some glycolytic
enzymes due to the presence of hidden targeting signals in
the readthrough extensions [39]. In our previous work, we
identified physiologically relevant genes regulated by transla-
tional readthrough by combining the RTP scores with a search
for PTS in the C-terminal extensions. LDHB, the heart subunit
of lactate dehydrogenase (LDH), was found to have the high-
est combined score, i.e. the highest combined score of RTP
value and probability of containing a PTS in the extension
[15]. Readthrough of the LDHB SCC and the full-length
gene was confirmed experimentally and it was shown that
the readthrough-extended isoform of LDHB is imported into
peroxisomes via the hidden PTS1 [15,16].
RTP prediction yielded 57 human readthrough candi-
dates with the high-readthrough consensus [15,17]. Malate
dehydrogenase 1 (MDH1) showed the highest RTP. MDH1
was also detected as a potential readthrough protein by phy-
logenetic analysis [14] and ribosome profiling in human
foreskin fibroblasts [8]. MDH1 mediates reversible conversion
of malate and NADþ to oxaloacetate and NADH and at least
two isoforms are present in eukaryotic cells. Mitochondrial
MDH1 is involved in the citric acid cycle, and the cytoplas-
mic form supports the malate–aspartate shuttle across the
mitochondrial inner membrane [40]. MDH1, like LDHB, is
extended by translational readthrough and transported into
peroxisomes via a hidden PTS1 [16]. Interestingly, earlier pro-
teomic analysis had already found MDH1 in mammalian
peroxisomes [41,42].
In this study, we analyse the stop codon readthrough of
MDH1. We show that readthrough is dependent on the
SCC, but not on the subsequent 50 nucleotides. By employing
a quantitative assay, we show that MDH1 readthrough is
tissue-specific and exceeds LDHB readthrough in all tested
cell types. We demonstrate that the MDH1x (extended
protein) stop codon encodes tryptophan and arginine. This
natural stop codon recoding, which is stimulated by theSCC, constitutes a modification of the genetic code in
humans. Furthermore, we provide evidence that the higher
degree of conservation of MDH1 readthrough in comparison
to LDHB readthrough co-evolved with the targeting signal
strength of their respective PTS1.2. Results
2.1. Analysis of the malate dehydrogenase stop codon
readthrough
In silico modelling of translational readthrough of SCCs
based on experimental readthrough data revealed a consen-
sus motif for the SCCs of genes containing high RTP values
[15]. MDH1 was the protein with the highest RTP score in
this model (electronic supplementary material, figure S1).
Ribosome profiling and genome searches for readthrough
genes also identified MDH1 [8,14,16]. To analyse the transla-
tional readthrough in detail, we expressed the SCC of MDH1
comprising 10 nucleotides upstream and downstream of the
stop codon in a dual reporter containing N-terminal Venus
and C-terminal humanized Renilla luciferase (hRLuc) tags
in HeLa cells. Luminescence indicated readthrough of the
SCCs, and Venus fluorescence served as an internal
expression control. As positive controls we used a vector
without any SCC (pDRVL) or the SCCs with the trypto-
phan-coding TGG instead of the TGA stop codon. The
background readthrough level was derived from a construct
containing two consecutive stop codons separating the
Venus and luciferase tags (figure 1a) [15]. Readthrough was
expressed as hRLuc luminescence divided by Venus fluor-
escence (in arbitrary units) and ratios were normalized to
the 100% controls. Readthrough of the MDH1 SCC was
4.34+ 0.51% (figure 1a). To analyse the influence of the
SCC on readthrough, we mutated the stop codon and/or
changed the trinucleotide sequence following the stop
codon (position þ4 to þ6). Mutation of the stop codon
itself or the C in position þ4 of the SCC (UGA CUA, position
þ4 underlined) reduced readthrough significantly to back-
ground level. Mutation of the nucleotides in position þ5
or þ6 (UGA CUA, positions þ5 and þ6 underlined) also
significantly decreased readthrough compared with the
wild-type SCC, but still showed levels between 0.4 and
0.8% (figure 1a). In conclusion, the readthrough motif confers
high readthrough to the MDH1 SCC and all tested nucleotide
changes in the consensus UGACUA (stop codon underlined)
lead to a significant decrease in readthrough.
Readthrough of the (first) MDH1 stop codon is expected
to give rise to an MDH1 isoform with a 19 amino acid exten-
sion, including the amino acid encoded by the stop codon.
We term this isoform MDH1x for extended.
We now turn from the analysis of the SCC to the full-
length MDH1. To confirm the extension of the protein by
stop codon suppression, we expressed full-length MDH1
including the 57 nucleotides following the stop codon in a
dual-tagged vector containing an N-terminal HA-tag and a
C-terminal myc-tag replacing the second stop codon
(figure 1b). Expression was analysed by western blotting
and showed 4.3+0.82% full-length MDH1x (figure 1c),
which is in agreement with readthrough measured for the
MDH1 dual reporter construct. Readthrough of the MDH1




























































































Figure 1. Translational readthrough of human malate dehydrogenase. (a) The SCC of MDH1 promotes a high level of translational readthrough. Venus/hRluc dual
reporter assay with MDH1 wild-type and mutant SCCs in HeLa cells. Red line indicates background level of readthrough as observed with a construct containing two
consecutive UAA stop codons separating Venus and luciferase tags. Mutations are indicated in red. Alterations of the SCC dramatically reduce readthrough efficiency.
N ¼ 3; *p, 0.01, #p , 0.05 versus WT (UGA CUA) (Student’s t-test). (b) Full-length MDH1 is extended by readthrough. Geneticin (100 mg ml21) induces MDH1
readthrough. Western blot of MDH1x (UGA) or MDH1x-UGG (stop codon replaced by Trp codon UGG) containing an N-terminal HA- and a C-terminal myc-tag.
Molecular mass marker in kilodaltons; n.t., not transfected. (c) Quantification of (b). MDH1x readthrough is 4.3+ 0.82%, treatment with geneticin induced read-
through to 13.1+ 1.17% (IMAGEJ, N ¼ 3, *p ¼ 0.002). (d ) Dual reporter assay with MDH1x wild-type SCC (SCC0) and MDH1x SCC containing the complete (SCCx)
or 31/57 nucleotides (SCCxD26, deletion of the last 26 nucleotides) of the extension. Readthrough does not differ significantly between the constructs, suggesting






 on January 12, 2017http://rsob.royalsocietypublishing.org/Downloaded from (G418) to 13.1+ 1.17% (figure 1c), reliably confirming that
the detected signal is consistent with readthrough.
The correspondence of the readthrough level measured
for the SCC and the stop codon of the full-length protein
suggests that the SCC is the main contributor to stop codon
readthrough of MDH1. To analyse the possible influence
of the nucleotides following the MDH1 SCC or of mRNA
secondary structures that are formed by this sequence onreadthrough in more detail, we expressed the MDH1 SCC
together with the full downstream stretch of 57 nucleotides
encoding the PTS1 (SCCx, full extension), the SCC with
only 18 nucleotides following the stop codon (SCCxD26, del-
etion of 26 nucleotides upstream of the second stop), or the
SCC alone (SCC0) in a dual reporter experiment. In addition,
we expressed the MDH1 SCC together with a scrambled









































Figure 2. MDH1 readthrough in several cell types and in comparison to LDHB. (a) MDH1 stop codon readthrough in various mammalian cell lines. HeLa, U373 and
U118 cells were transfected with MDH1 and LDHB SCC reporter constructs and analysed by dual reporter assays. Readthrough is expressed as hRLuc/Venus signal.
MDH1 readthrough is significantly higher compared with LDHB readthrough in all cell lines (*p ¼ 0.001 (U373), p ¼ 0.002 (HeLa), p ¼ 0.001 (U118); Student’s t-
test). MDH1 and LDHB readthrough are highest in U118 cells. MDH1: #p ¼ 0.01 (U118 versus HeLa), p ¼ 0.01 (U118 versus U373). LDHB: p ¼ 3  1027 (U118
versus HeLa), p ¼ 8  1025 (U118 versus U373); Student’s t-test; N ¼ 5. (b) Geneticin (100 mg ml21) induces MDH1 readthrough in U373, HeLa and U118 cells.
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extension but would not form the same secondary structure.
Measurement of reporter activity shows that readthrough effi-
ciency is not affected by the partial, the complete, or
the scrambled nucleotide sequence following the SCC
(figure 1c). RNA structure predictions of the MDH1 SCC
and the readthrough extension did not reveal conserved
structures (electronic supplementary material, figure S2).
Hence, we conclude that the 50 nucleotides downstream of
the MDH1 SCC appear to be dispensable for the modulation
of readthrough of the MDH1 stop codon; readthrough of the
MDH1 stop codon depends mostly on the SCC. It cannot be
excluded, however, that sequence elements downstream of
the second stop codon contribute to translational read-
through. Indeed, secondary structure prediction of aligned
mammalian MDH1 30UTRs revealed predicted hairpin
structures that may influence readthrough (electronic sup-
plementary material, figure S2c). These structural elements
are conserved in mammals (electronic supplementary
material, figure S3) but they were not found to be conserved
in the alignment of vertebrate MDH1 30UTRs.2.2. Cell type specificity of MDH1 readthrough
When analysing the LDHB SCC in HeLa, HEK, COS-7 and
U118 cells using our reporter assay, readthrough was found
to be highest in the glioblastoma cell line U118 [15]. We there-
fore were curious to find out whether MDH1 readthrough
would differ in different cell lines. We performed the dual
reporter assay in HeLa cells and two glioblastoma cell lines,
U118 and U373, and compared MDH1 and LDHB read-
through. Readthrough of the MDH1 SCC was 4.91+0.74%
in U373 cells and reached 10.3+3.8% in U118 cells
(figure 2a,b). In all tested cell lines readthrough of the MDH1
SCC was more than twice the level of the LDHB SCC, and
both SCCs showed the highest readthrough in U118 cells
(figure 2a). As before, readthrough was inducible by geneticin.
Induction factors ranged between 2.6 in U373 and 3.7 in HeLa
cells (figure 2b). Under geneticin treatment readthrough of the
MDH1 SCC rose to 36+10% in U118 cells (figure 2b). Theseresults indicate that readthrough is dependent on and possibly
differentially regulated in different cell types.
2.3. The MDH1 stop codon encodes tryptophan and
arginine
Which amino acids are incorporated during readthrough
when the stop codon is at the A (aminoacyl-tRNA) site of the
ribosome? To answer this question, we expressed C-terminally
myc-taggedMDH1x inHeLa cells and immunoprecipitated the
fusion protein using anti-myc antibodies. The corresponding
construct with the sense codon TGG was used as a control
representing full readthrough with incorporation of trypto-
phan. Precipitated proteins were detected initially by western
blottingwith anti-myc antibodies (insets in figure 3a,b). Regions
of interest were excised from a gel stained with colloidal
Coomassie and subjected to mass spectrometric protein identi-
fication (figure 3a,b and insets). The tryptophan-containing
tryptic peptide corresponding to the readthrough region was
readily identified by liquid chromatography coupled to mass
spectrometry (LC-MS) in the case of the control construct
(figure 3a,c). When analysing the MDH1x proteins, we also
detected tryptophan and additionally found arginine, cysteine,
glutamine and phenylalanine (electronic supplementary
material, table S1). Next, we applied a more stringent criterion
for mass spectrometric evidence: the detection of the intact pre-
cursor peptide with a high mass accuracy of 3 ppm relative
deviation in coincidence with fragment ion series covering
the readthrough position. Using this filter, we confirmed the
incorporation of tryptophan and arginine in place of the stop
codon (figure 3b,d; electronic supplementary material, table
S1). These data suggest that in the endogenous readthrough
of the human MDH1 stop codon, the stop codon can encode
tryptophan and arginine.
2.4. Conserved functional translational readthrough of
malate dehydrogenase
In our previous study, we searched for transcripts that com-




















































Figure 3. Tryptophan and arginine are incorporated during readthrough at the MDH1 stop codon. (a,b) LC-MS analysis (base peak intensity chromatogram, BPI) of
the tryptic peptides derived from the gel regions that are marked by rectangles in the colloidal Coomassie-stained gel lane shown in the inset. WB: specific detection
of myc-tagged proteins by western blotting used to identify gel regions of interest. Intense bands at an apparent molecular weight of approximately 50 kDa and
approximately 20 kDa correspond to antibody heavy and light chains, respectively. (c,d ) Mass-selective chromatographic display of the readthrough-related tryptic
peptides. Extracted ion chromatograms (XIC) show the peptides resulting from incorporation of Trp (triply charged molecular ion, green trace) or of Arg (doubly
charged molecular ion, red trace). Analysis of the MDH1x-derived proteins (d ) not only confirmed the presence of Trp as seen in the control scenario with Trp-coding
(c), but additionally revealed the incorporation of Arg that is undetectable in the control. Signal intensities of the two peptides do not reflect the ratio of incor-
poration of Trp and Arg, respectively. The generated peptides considerably differ in their ionization behaviour, which is particularly due to the emergence of an
additional tryptic cleavage site upon incorporation of Arg. For generation of XIC, a mass tolerance window of 20 ppm was applied to continuum data without lock
mass correction. Major signals are labelled with the corresponding amino acid sequence together with the fragment ions detected by mass spectrometric





 on January 12, 2017http://rsob.royalsocietypublishing.org/Downloaded from PTS1 in the readthrough extension [15]. In silico analysis of all
SCCs of the human genome revealed a high probability of a
hidden PTS1 in the readthrough extension of MDH1x. The
distribution of RTPþ (positively scaled and normalized
RTP)  PTS1 product scores over all human transcripts indi-
cates that MDH1x is one of the transcripts containing high
RTP and high PTS1 probability (electronic supplementary
material, figure S4). Furthermore, MDH1x is targeted to the
peroxisome via translational readthrough resulting in
expression of the hidden targeting signal [16]. To analyse
the endogenous peroxisomal localization of MDH1, we
stained endogenous MDH1 and the peroxisomal markers
Pex14 or PMP70 in HeLa and HEK cells. As expected, we
found that MDH1 is mainly localized in the cytoplasm
(figure 4a,b). To identify the peroxisomal MDH1, we washed
out the cytosol with phosphate buffered saline (PBS) after
cell permeabilization by digitonin. After cytosol removal,
endogenous MDH1 was readily detected in peroxisomes
(figure 4a,b). To be able to test whether the hidden targeting
signal in the MDH1x extension is responsible for peroxisome
targeting, we transfected HeLa cells with YFP-tagged
MDH1x. The fusion protein could be detected in the peroxi-
somes after removal of the cytosol (figure 4c). To prove that
targeting of MDH1x to the peroxisomes is dependent on the
type of the stop codon, we mutated the stop codon UGA to
the more efficient stop codon UAA. This tighter stop codon
reduced the peroxisomal targeting of MDH1x (figure 4d).When the stop codon was mutated to a sense codon (UGG,
tryptophan-coding), peroxisomal localization of MDH1x was
strongly increased and obvious even without washing out
the cytosol (electronic supplementary material, figure S5a).
To show that peroxisomal targeting of MDH1x is dependent
on the hidden PTS1 in the extension, we mutated the PTS1
in the extension by deletion of the leucine residue (DL) in
the CRL-terminus. This mutation blocks import of MDH1x
into peroxisomes (electronic supplementary material,
figure S5b), indicating that expression of the PTS1 in the
extension is necessary for peroxisomal targeting of MDH1x.
Furthermore, to test whether functional readthrough of
the MDH1 stop codon is a general property, we stained
endogenous MDH1 in two glioblastoma cell lines, U118 and
U373, and in murine cardiomyocytes. Immunofluorescence
with antibodies directed against MDH1 and the peroxisomal
membrane proteins PMP70 and Pex14 showed mainly cyto-
plasmic localization of the endogenous MDH1 (electronic
supplementary material, figure S6a). After removal of the
cytosol, we found that MDH1 is localized to peroxisomes in
all cell types tested (electronic supplementary material,
figure S6a). In cardiomyocytes, endogenous MDH1 is already
detectable without removal of cytosol (electronic supplemen-
tary material, figure S6b). This indicates that the readthrough-
extended isoform of MDH1 is imported into peroxisomes in
various cell types and further substantiates the evolutionary
conservation of peroxisomal requirement of MDH1.
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Figure 4. Functional translational readthrough of MDH1. Immunofluorescence with anti-MDH1 and anti-Pex14 in untransfected HeLa (a) and HEK (b) cells. Endogen-
ous MDH1 shows mainly cytosolic localization. Removal of cytosol (-CYT) after digitonin treatment reveals colocalization of MDH1 with the peroxisomal markers
Pex14 and PMP70. (c) Peroxisomal targeting of MDH1x depends on the stop codon. Direct immunofluorescence microscopy of transfected HeLa cells: MDH1 localizes
mainly to the cytosol. Removal of cytosol (-CYT) after digitonin permeabilization reveals peroxisomal localization of MDH1. (d ) Exchange of UGA with the tighter stop
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PTS1 are a common feature in mammals and vertebrates,
we performed a phylogenetic analysis on MDH1 transcript
sequences of a wide range of vertebrate species. The multiple
alignment of potential readthrough extensions of MDH1x
orthologues in mammalian and non-mammalian vertebrates
illustrates that the extension including the hidden PTS1 is
conserved among these species (figure 5a), supporting the
notion that the hidden PTS1 is functional in all vertebrates.
All mammalian MDH1x PTS1 contain the terminal tripeptide
CRL, and all non-mammalian PTS1 contain SRL.
Next, we calculated PTS1 prediction scores for the
MDH1x proteins of the alignment (figure 5a). We found
that the non-mammalian signal (SRL) is predicted to be the
more efficient PTS1 when compared with the hidden PTS1
found in mammalian MDH1x (CRL) (figure 5a). This
coincides with the exclusive presence of LDHBx in mammals.
To prove the functionality of these putative PTS1 motifs,
we transfected HeLa cells with a Venus-tagged construct
expressing the last 10 amino acids from the human MDH1x
(terminating tripeptide CRL) and from zebra finch
(Taeniopygia guttata) MDH1x (terminating tripeptide SRL).
The Venus-tagged PTS1 derived from the peroxisomal matrix
protein ACOX3 was used as a positive control. Cells were co-
stained with anti-Pex14 antibody. Both human and zebra
finch Venus-MDH1-PTS1 localize to peroxisomes in HeLa
cells (figure 5b). This indicates that both zebra finch andhuman MDH1x PTS1 are functional and that both SRL and
CRL are good targeting signals for peroxisomal import. To
evaluate the differences in mammalian and non-mammalian
MDH1x peroxisomal targeting,we compared the targeting effi-
ciencies of zebra finch and human PTS1 quantitatively. To
analyse the relative targeting efficiency fluorescence signals
of the cells before and after removal of cytosol were analysed
and the ratio of peroxisomal versus total signal of the PTS1 con-
structs was calculated. We found that 43% more of zebra finch
MDH1x PTS1was localized to the peroxisomes comparedwith
the human MDH1x PTS1. This indicates that the zebra finch
PTS1 terminating in SRL is a more efficient targeting signal
than the human CRL PTS1 (figure 5d ).3. Discussion
3.1. Functional translational readthrough generates
MDH1x
Translational readthrough has only recently been identified
and systematically analysed in mammals [17]. Three systems
biology approaches, ribosome profiling, phylogenetic analy-
sis, and regression modelling, are being used to search for
new protein isoforms arising from stop codon readthrough
[17]. MDH1x is the only protein that has been identified by









































































































Figure 5. Assessing the ‘bird gap’: comparative analysis of the zebra finch and human hidden PTS1. (a) Alignment of MDH1x termini in mammals and non-
mammalian vertebrates. MDH1x is conserved throughout vertebrates. Red box marks readthrough extension. Bracket on the right-hand side: Mammals. PTS1
score calculation suggests that mammalian MDH1x PTS1 is weaker than the PTS1 of non-mammalian vertebrate MDH1x. Non-mammalian species, however, do
not have LDHBx (bird gap). (b) PTS1 of both human and zebra finch (Taeniopygia guttata) MDH1x localize to peroxisomes. PTS1 from peroxisomal membrane
protein ACOX3 was used as a positive control. Scale bar, 10 mm. (c) Quantitative live analysis of peroxisomal protein import efficiency. Venus-tagged PTS1
was expressed in HeLa cells. After digitonin permeabilization of the plasma membrane, the cytoplasm was washed out by PBS. Hundred cells from images
pre and post removal of cytoplasm were used to calculate import efficiency. (d ) Analysis of Venus fluorescence before and after removal of cytoplasm revealed
that targeting efficiency of zebra finch Venus-tagged MDH1x PTS1 is more efficient compared with human MDH1x PTS1. **p ¼ 0.005 versus human PTS1 (Student’s
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characterize endogenous stop codon readthrough [15]. The
SCC motif [14–16] responsible for high readthrough levels
is found in 57 human translational readthrough candidates.
Of those, MDH1 has the highest RTP.Readthrough of the MDH1 stop codon is dependent on
the SCC motif UGA CUA (stop codon underlined). At this
point, there is no general agreement whether readthrough
is mainly influenced by the SCC or whether cis-acting
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tative assay that enabled us to compare readthrough levels
of different SCCs, and to analyse readthrough in different
cell lines. We show here that the mRNA sequence down-
stream of the MDH1 SCC is not required to obtain the 4%
readthrough that is already sponsored by the SCC alone.
The predicted mRNA structure of the MDH1 extension is
not conserved, which is in agreement with our finding that
translational readthrough of MDH1 is not dependent on the
full extension but rather on the SCC alone. Nevertheless,
these findings do not preclude a role of the extension in gen-
eral, such as for RNA stability, or a contribution of the mRNA
elements downstream of the second stop codon.
MDH1 readthrough was present in all cell types analysed
in our study, and was found to be highest in U118 glioblas-
toma cells. The different readthrough properties of these
cell lines could be due to different levels of metabolic dysre-
gulation following the oncogenic transformation of these cells
that could manifest in different tRNA or release factor
concentrations.
In agreement with the higher RTP value of MDH1, read-
through intensity of MDH1 exceeded LDHB readthrough
more than twofold in all tissues tested. LDHB readthrough
was also highest in U118 cells, suggesting an overall increase
in readthrough probability in these cells that is possibly due
to the different metabolic regulation.
MDH1 is also known to contain a functional hidden PTS1
in the extension [16] and endogenous MDH1 is present in the
peroxisomes of HeLa cells, HEK cells, glioblastoma cell lines
and murine cardiomyocytes.3.2. Translational readthrough constitutes a
modification of the genetic code in humans
The fidelity of amino acid incorporation at the ribosome
is controlled by selection of the tRNA and by kinetic proof-
reading after GTP hydrolysis by the elongation factor [43].
Compared with cognate and near-cognate tRNAs, non-cognate
tRNAsare not able to induceGTPhydrolysis. Structural analysis
of ribosomes revealed that the shape of the base pairs, and not
numbers or types of hydrogen bonds, determines tRNA selec-
tion [44], and that ‘geometrical mimicry’ by non-standard base
pairings can lead to incorporation of near-cognate tRNAs [45].
In this study, we show amino acid incorporation during
endogenous readthrough of a human protein in the absence
of pharmacological induction or other readthrough-
enhancing conditions. Mass spectrometric analysis provided
evidence of predominant incorporation of tryptophan
(codon UGG) and arginine (codons CGX, AGR; X ¼ A,G,C,
or U; R ¼ A or G) at the UGA stop codon of human MDH1x.
This finding suggests that readthrough of stop codons results
from stop codon recognition by near-cognate tRNAs, as they
can form at least two out of the three pairings with the stop
codon. Our results support the observation that the second
position of the stop codon is crucial for acceptance of a tRNA
at the A-site of the ribosome [46], and that mispairing occurs
at the first or third position of the stop codon.
The first systematic mass spectrometric analysis of the
amino acids incorporated at stop codons was undertaken
recently in Saccharomyces cerevisiae using the high read-
through strain [PSIþ] [46]. Glutamine, lysine and tyrosine
were found to be incorporated at UAA and UAG stopcodons, and tryptophan, arginine and cysteine at the UGA
stop codon. Endogenous readthrough of premature ter-
mination codons in yeast leads to insertion of tryptophan,
arginine and cysteine [47]. These results in yeast agree with
the identification of the corresponding suppressor tRNAs
using in vitro expression systems or E. coli infected with
RNA phage Qb [3,5,48–50].
Using an in vitro expression system, mass spectrometric
analysis of amino acid incorporation in rabbit b-globin also
found tryptophan, arginine, cysteine and, additionally,
serine at the UGA stop codon [11]. In vitro expression of the
murine leukemia virus pol gene leads to formation of a
fusion protein due to readthrough of the UGA stop codon.
During this process, tryptophan, arginine and cysteine are
integrated at this stop codon [51].
Whether the other nucleotides of the SCC influence
amino acid incorporation during the readthrough process is
still not known. On the one hand, it was suggested that the
surrounding nucleotides have no influence on amino acid
incorporation [46], but another study in yeast shows that
the UGA stop codon followed by A is preferentially read-
through by Trp-tRNA, whereas it is readthrough by Cys-
tRNAs when followed by G or C [52].
Moreover, it would be helpful to determine whether the
amino acid profile changes when readthrough is induced
pharmacologically. Recent work in yeast indicates that the
same amino acids are incorporated at the UGA stop codon,
but with different insertion frequencies [47].3.3. Potential roles of a peroxisomal malate
dehydrogenase
Malate dehydrogenase is universally present in peroxisomes
and employs a surprising variety of targeting strategies: plants
contain two peroxisome-specific MDH genes which are targe-
ted to the peroxisome via PTS type 2 [53–57]. Saccharomyces
cerevisiae has three MDH isoforms: mitochondrial MDH1, cyto-
plasmatic MDH2 and peroxisomal MDH3. The latter uses a
dedicated PTS1 [58–63]. In Yarrowia lipolytica, a peroxisome-
specificMDH isoform results from alternative splicing, creating
anmRNA containing a PTS1 [64]. Proteomic analyses addition-
ally found MDH1 in mammalian peroxisomes [41,42]. Taken
together, these findings suggest the evolutionary conservation
of MDH1 requirement in peroxisomes.
In S. cerevisiae, peroxisomal b-oxidation is blocked when
the MDH3 gene is disrupted [59]. Peroxisomal b-oxidation of
fatty acids requires a peroxisomal pool of NADþ, which is
reduced to NADH in this process. However, neither NADþ
nor NADH are able to cross the peroxisomal membrane
[59,65,66]. NADþ, therefore, has to be recycled from NADH
within the peroxisome. As MDH catalyses the conversion of
oxaloacetate and NADH to malate and NADþ, it was hypoth-
esized that MDH3 is involved in this process [59]. The
identification of MDH1x provides a mechanistic explanation
for MDH1 import into peroxisomes of vertebrate cells and
suggests that in all cell types, MDH is potentially involved
in regeneration of redox equivalents in the peroxisomal matrix.
The universal presence of MDH in peroxisomes may
suggest a malate shuttle across the peroxisomal membrane
of vertebrate cells resembling the aspartate–malate shuttle
of the mitochondrial membrane that was first identified in
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NADH [69] and, therefore, NADH has to be generated by
mitochondrial MDH. The oxoglutarate : malate antiporter
imports malate into the mitochondrial matrix where it is con-
verted to oxaloacetate. Oxaloacetate is then converted to
aspartate and shuttled back to the cytoplasm where oxaloace-
tate is regenerated, which is the substrate of the cytoplasmic
MDH. Strikingly, in yeast the cytoplasmic MDH2 is requi-
red for peroxisome function [70] lending support to our
hypothesis of a universal peroxisomal malate shuttle.
Mitochondrial andcytoplasmic aspartate aminotransferases
catalyse the interconversion of aspartate and oxaloacetate.
Remarkably, this protein was also found in peroxisomes of
S. cerevisiae and various plant species [71–73], which supports
thehypothesis of amalate/aspartate shuttle across the peroxiso-
mal membrane. However, disruption of the peroxisomal
aspartate aminotransferase in S. cerevisiae did not lead to a
b-oxidation defect, and mutants were able to grow normally
on oleate, thus indicating that the peroxisomal aspartate
aminotransferase is not essential for peroxisomal function [73].3.4. The antiquity of peroxisomal malate
dehydrogenase
LDHB can be readthrough-extended to form LDHBx and is
transported into the peroxisome by an otherwise hidden PTS1
[15]. The non-extended subunits of LDH, LDHA and LDHB,
can be transported into the peroxisome via piggyback transport
so that LDH tetramers are present inside peroxisomes [15,38].
The LDHBx extension including the hidden targeting signal is
conserved in mammals but it is not present in non-mammalian
species (bird gap). On the other hand, the MDH1x extension
and the hidden PTS1 are conserved in mammalian and non-
mammalian vertebrates, indicating evolutionarily conserved
peroxisomal targeting. Of note, all mammalian MDH1x
encode a PTS1 terminating with the tripeptide CRL. The PTS1
tripeptideof thenon-mammalianvertebrates (excluding amphi-
bia) is SRL,which ispredicted tobeamore efficientPTS1andwe
proved that PTS1 targeting of zebra finch PTS1 (SRL) is more
efficient than targeting of human PTS1 (CRL). We therefore
suggest that peroxisomal import of all non-mammalian ver-
tebrate MDH1x is more efficient compared with the MDH1x
import in mammals. Mammals, however, (also) have LDHBx.
We further hypothesize that the role which is shared between
peroxisomal LDH and MDH1x in mammals is carried out by
MDH1x alone in non-mammalian vertebrates. It is plausible
that the evolution of LDHBx in the mammalian clade was the
precondition for the weakening of the MDH1x PTS1.
LDHB andMDH1 are closely related, with MDH being the
evolutionarily older enzyme [74]. The amino acid sequence of
the halobacterial MDH, for example, shows greater sequence
similarity to other LDHs than to other MDHs [75], and its
X-ray structure is more similar to LDH than to other MDHs
[76]. Exchange of only one amino acid can convert bacterial
LDH substrate specificity from lactate to malate [77]. MDH
substrate specificity can also be changed from oxaloacetate to
pyruvate by one amino acid change [75]. These findings under-
line the close relation of both enzymes and thus support the
hypothesis that both exert similar functions in the peroxisome.
In the light of the common ancestry of MDH and LDH, it is
intriguing that both enzymes have adopted a modification
of the genetic code and harness the coding potential of the30 end of their transcripts. Functional translational readthrough,
therefore, expands the human proteome and the options of
its intracellular targeting.4. Material and methods
4.1. DNA cloning
Plasmids used in this study are listed in the electronic sup-
plementary material, table S2. Oligonucleotides used are
listed in the electronic supplementary material, table S3. Dual
reporter constructs were cloned based on pDRVL (PST1360)
encoding an N-terminal Venus tag and a C-terminal hRluc
tag [15]. For dual reporter constructs PST1521, 1523, 1581–82,
1525–26, 1473, 1474, 1475, 1476, 1479, 1480, 1481 and 1502,
oligonucleotides JH 77–78, JH 105, 106, 109, 110, 113, 114,
137–140, 161–164 and OST1463–1470 and 1475–1480 were
annealed and inserted into BspEI and BstEII sites of pDRVL.
For cloning of pEYFP-MDH1x (PST1436) theMDH1 open read-
ing frame including the stop codon and the 57 nucleotide 30
extension was PCR-amplified from human cDNA using pri-
mers OST1192 and 1193 and inserted into EcoRI and BamHI
sites of pEYFP-C1. The stop codonvariants pEYFP-MDH1xTGG
(PST1514) and pEYFP-MDH1xTAA (PST1535) were created by
amplifying MDH1x from PST1436 using primers OST1231 and
1232, and JH103 and 104. Similarly, the deletion of the last
amino acid in the cryptic PTS1 CRL, pEYFP-MDH1TGGxDL
(PST1536 deletion of the last amino acid in the cryptic PTS1
CRL) was created from PST1514 using primers OST1192 and
JH102. Full-length dual reporter construct pcDNA3.1-HA-
MDH1x-myc (PST1443) was cloned by amplification of
MDH1xfromPST1436withprimersOST1204and1205andinser-
tion into NheI and BamHI sites of pcDNA3.1/Myc-His(2)A.
The stop codon mutant pcDNA3.1-HA-MDH1TGG-myc
(PST1508) was generated by site-directed mutagenesis using
primers OST1231 and 1232. pEXP-N-Venus-PTS1-human
(PST1482) and pEXP-N-Venus-PTS1-zebra-finch (1483) were
cloned using Gateway technology (Invitrogen). After anneal-
ing of primers OST1245 and 1246, and OST1247 and 1248,
they were inserted into the entry vector pENTR/D-TOPO by
TOPO-D cloning reaction. Inserts were then transferred to
pEXP-N-Venus by site-specific recombination using the LR
reaction. All plasmids were confirmed by DNA sequencing.
4.2. Cell culture
HeLa cellsweremaintained in lowglucoseDulbecco’sminimal
essential medium (DMEM), and HEK, U118 and U373 cells in
high glucose DMEM. Culture media were supplemented with
1% glutamine, 5–10% heat-inactivated fetal calf serum (FCS),
100 units ml21 penicillin and 100 mg ml21 streptomycin. For
U118 and U373 cells, 1% non-essential amino acids and 1%
pyruvate were added to the media. Cells were transfected
using Effectene transfection reagent (Qiagen) as described by
the manufacturer. Six hours after transfection, transfection
reagent was removed and, as indicated, 100 mg ml21 geneticin
(G418) was added.
4.3. Dual reporter assays and readthrough calculation
For dual reporter assay, approximately 6500 cells were seeded
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were measured by the Renilla Luciferase Assay System
(Promega) and the Synergy Mx plate reader (Biotek). Cells
were washed with PBS and lysed in 30 ml Renilla Luciferase
Assay Lysis Buffer (Promega) according to the manufacturer’s
manual. Cells were loosened from the surface using a pipette
tip andwere incubated on a shaker for 15 min at room tempera-
ture. For fluorescence measurement 50 ml Renilla Luciferase
Assay Reagent without substrate was added per well and the
lysates were analysed at 485 nm excitation, 530 nm emission
(sensitivity: 130) in the plate reader. For hRluc luminescence
measurement, 50 ml Assay Reagent containing 2 substrate
was added to the lysates using an automated injector. Lumines-
cence was read 2 s after injection and integrated over 10 s
(sensitivity 150). Renilla Luciferase Assay Reagent plus PBS
was used as a blank control for both measurements. Each con-
struct was analysed in three to seven biological replicates.
The readthrough rateswere calculated as explained [15]. Briefly,
the ratio of hRluc/Venus fluorescence was calculated, and the
construct ratios of pDRVL were set to 100%. For measurement
of SCCx, SCCxScr and SCCxD26, pDRVL containing the same
insert with TGG mutation of the stop codon was used as
100% control. Arithmetic mean and standard error of the
mean (s.e.m.) were calculated for each construct from its
biological replicates.4.4. Immunofluorescence and microscopy
Transfected MDH1 constructs and endogenous MDH1 were
detected in HeLa cells by combined direct/immunofluores-
cence experiments. Approximately 105 cells were seeded on
coverslips and transfected as indicated by Effectene Transfec-
tion Reagent as described above. Coverslips were coated with
laminin (Sigma) for U118 cells and with poly-L-lysine (Sigma)
for HEK cells. For removal of cytosol, cells were treated with
0.02% digitonin (Invitrogen) for 5 min at room temperature.
Cells were fixed with 10% formaldehyde for 20 min, and per-
meabilized using 0.5% Triton X-100 in PBS for 5 min. After
blocking for 20 min at 378C with 10% BSA in PBS, antigens
were labelled with primary antibodies at 378C for 1 h. Pri-
mary antibody dilutions in blocking buffer were 1 : 200
rabbit anti-PEX14 (ProteinTech), 1 : 100 mouse anti-MDH1
(Abcam), 1 : 100 rabbit anti-MDH1 rabbit (Sigma) and 1 : 500
mouse anti-PMP70 (Sigma). Secondary labelling was
done for 1 h with antibodies (1 : 200) conjugated to Cy3
or Alexa647 (Jackson Immuno Research), or Alexa488
(MoBiTech). Coverslips were mounted with Vectashield
mounting medium with DAPI (Vector Laboratories). Isolation
of mouse cardiomyocytes was done by Langendorff perfusion
and collagenase type II (2 mg ml21, Worthington Biochemical
Corporation) digestion. Jonas Peper isolated cardiomyocytes
using published protocols [78,79]. Freshly isolated cardiomyo-
cytes were seeded on laminin-coated coverslips for 60 min.
Cells were fixed with 4% paraformaldehyde for 10 min and
incubated in blocking solution (10% FCS, 0.2% Triton X-100
in PBS) for 1 h. Primary and secondary antibodies were
diluted as mentioned above in blocking buffer and incubated
overnight at 48C. Fluorescence microscopy was done using a
100 oil objective (1.3 NA) with a Zeiss Imager M1 fluor-
escence wide field microscope equipped with a Zeiss
AxiocamHRm Camera and Zeiss AXIOVISION 4.8 acquisition
software. z-Stacks with 20 images and 0.2 mm spacing wererecorded and subjected to deconvolution. Linear contrast
enhancements were applied using AXIOVISION software.
4.5. Cell lysis, western blot analysis
Cells were lysed in RIPA lysis buffer (20 mM Tris–HCl, pH
7.4, 150 mM sodium chloride, 2 mM EDTA, 1% NP40,
1 mM DTT, 0.1 mM PMSF, Complete protease inhibitors
(Roche)), 24 h after transfection. Proteins were separated by
SDS-PAGE on a 12% gel, transferred to a nitrocellulose mem-
brane and probed with primary and secondary antibodies.
The following antibodies were used at a 1 : 1000 dilution:
rabbit polyclonal anti-HA (Abcam), mouse monoclonal
anti-myc (Cell Signaling), and mouse monoclonal anti-tubu-
lin (Sigma). HRP-conjugated goat anti-rabbit IgG and
donkey anti-mouse IgG (Jackson Immuno Research) were
used as secondary antibodies at 1 : 5000. Reactive bands
were revealed with Lumi-light and Lumi-light plus western
blotting substrate (Roche). Luminescence was recorded
using luminescent image analyser LAS 4000 (Fuji). Densito-
metric analysis was done using IMAGEJ. Readthrough was
expressed as ratio of: intensity of MDH1x band (readthrough
band)/intensity of MDH1x band þ intensity of MDH band.
4.6. Immunoprecipitation and mass spectrometric
analysis
HeLa cells were seeded in a 10 cm-plate and transfected with
C-terminally myc-tagged MDH1x and MDH1TGGx con-
structs (PST1443 and PST1508); 24 h after transfection, cells
were harvested and lysed in 200 ml Cellytic buffer (Sigma)
with 1 mM DTT, 1 mM EDTA and Complete protease inhibi-
tors (Roche) for 30 min on ice. After centrifugation, 3 ml anti-
myc-antibody (Cell signaling) was added to the supernatant
and the mixture was incubated for 1 h at 48C on a rotating
wheel, then 20 ml PBS-washed protein G agarose beads
(Thermo Scientific) were added for 3 h at 48C. Beads were
washed 3 with Cellytic and 3 with PBS. Bound proteins
were eluted with 4 Roti-Load2 (Roth). IP efficiency was ana-
lysed by western blot using 1/4 of the sample, and 3/4 were
used for mass spectrometric analysis. For this purpose,
proteins were separated on precast TG PRiME Tris/glycine
8–16% gradient gels (Serva) and visualized by colloidal
Coomassie staining. Gel regions of interest were excised
manually and subjected to automated in-gel digestion with
trypsin as described previously [80]. Nanoscale reversed-
phase UPLC separation of tryptic peptides (peptides resulting
from trypsin digestion) was performed with a nanoAcquity
UPLC system equipped with a Symmetry C18 5 mm, 180
mm  20 mm trap column and a BEH C18 1.7 mm, 75 mm 
100 mm analytical column (Waters Corporation). Peptides
were separated over 60 min at a flow rate of 300 nl min21
with a linear gradient of 1–45% mobile phase B (acetonitrile
containing 0.1% formic acid) while mobile phase A was
water containing 0.1% formic acid. Mass spectrometric analy-
sis of tryptic peptides was performed using a Synapt G2-S
quadrupole time-of-flight mass spectrometer equipped with
ion mobility option (Waters Corporation). Positive ions in
the mass range m/z 50–2000 were acquired with a typical res-
olution of at least 20 000 FWHM (full width at half maximum)
and data were lock mass corrected post-acquisition. Data
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were searched against a custom database with 21 entries,
which was compiled on the basis of the construct sequence
by introducing each of the proteinogenic amino acids or a
one-residue gap in the readthrough position. Precursor and
fragment ion mass tolerances were typically below 5 ppm
for precursor ions and below 10 ppm (root mean square)
for fragment ions. Carbamidomethylation of cysteine and oxi-
dation of methionine were specified as variable modifications.
One missed trypsin cleavage was allowed.
4.7. In vivo measurement of peroxisomal protein import
efficiency
HeLa cells were seeded in 6-well plates on coverslips, trans-
fected with Venus-tagged MDH1 targeting signals (last 10
amino acids from zebra finch and human MDH1x) and trans-
ferred into a live imaging chamber. Cells were maintained in
physiological buffer (in mM: 140 NaCl, 2.5 KCl, 1.8 CaCl2,
1.0 MgCl2, 20 glucose, 20 HEPES, pH 7.4) and were imaged
using a Zeiss Imager M1 fluorescence wide field microscope
equipped with a Zeiss AxiocamHRm Camera and Zeiss
AXIOVISION 4.8 acquisition software. The buffer was then
exchanged with buffer containing 0.006% digitonin (Sigma) to
permeabilize the cells and remove the cytoplasm. Fluorescence
was measured eachminute for 12 min in total. After 12 min the
chamberwaswashed againwith fresh buffer to remove remain-
ing cytoplasmic fluorescence. Mean fluorescence intensity of
100 cells of the 0 min-image and the image after the last wash
were measured using IMAGEJ. After background subtraction,the ratio of fluorescence pre and post digitonin wash was
calculated to analyse import efficiency.
4.8. Statistics
Statistical analysis was done with EXCEL using the Student’s
t-test for repeated measurements. Data were presented as
means+ s.e.m. (standard error of the mean). p-values, 0.05
were considered statistically significant.
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